Canada \u00b7 Alternatives
Ozempic alternatives in Canada: what's actually authorized.
Searches for “Ozempic alternatives Canada” spiked after shortages and the 2026 generic approvals. Below is every Health Canada-authorized option we track, plus what is not authorized. This is information, not a recommendation.
Same molecule (semaglutide)
- Wegovy — semaglutide for chronic weight management.
- Rybelsus — oral semaglutide tablet for type 2 diabetes.
- Generic semaglutide — first G7 generics authorized in 2026.
Other authorized GLP-1 / dual agonists
- Mounjaro and Zepbound — tirzepatide (GIP/GLP-1).
- Saxenda — liraglutide for weight management (Victoza for type 2 diabetes).
Full class overview: GLP-1 medications in Canada.
Not authorized alternatives
- Retatrutide and other investigational agonists.
- Compounded or “research” semaglutide / tirzepatide vials — see Health Canada's April 2026 advisory and our compounded GLP-1 Canada page.
- Unapproved peptides marketed for weight loss — see weight-loss peptides in Canada.
Coverage and side effects
What semaglutide users report
- 37 published anonymous semaglutide confessions; 5 mention at least one side effect.
- 12 mention Ozempic, Wegovy or Rybelsus by name.
- Among confessions that state a weight change in pounds, the median reported is 50 lb. Self-reported, unverified.
Most-mentioned side effects (share of semaglutide confessions):
- Burping: 5.4% (2)
- Nausea: 5.4% (2)
- Vomiting: 5.4% (2)
- Anxiety or panic: 2.7% (1)
- Constipation: 2.7% (1)
Counts are phrase mentions in anonymous accounts, not diagnoses or clinical rates. Full breakdown and methodology: semaglutide side-effects report.
What tirzepatide users report
- 93 published anonymous tirzepatide confessions; 27 mention at least one side effect.
- 10 mention Mounjaro or Zepbound by name.
- Among confessions that state a weight change in pounds, the median reported is 50 lb. Self-reported, unverified.
Most-mentioned side effects (share of tirzepatide confessions):
- Heart rate or palpitations: 11.8% (11)
- Anxiety or panic: 5.4% (5)
- Burping: 4.3% (4)
- Insomnia or poor sleep: 3.2% (3)
- Libido: 3.2% (3)
Counts are phrase mentions in anonymous accounts, not diagnoses or clinical rates. Full breakdown and methodology: tirzepatide side-effects report.
By province and city
Authorized alternatives compared
Main trial averages, drug vs placebo.
| Drug | How often | Average weight change |
|---|---|---|
| Saxenda (liraglutide) | Daily | 8.0% vs 2.6%, 56 weeks |
| Wegovy (semaglutide) | Weekly | 14.9% vs 2.4%, 68 weeks |
| Zepbound (tirzepatide) | Weekly | About 15% to 21% vs 3%, 72 weeks |
Last reviewed October 15, 2026against Health Canada's Drug Product Database and trial publications and Health Canada.
Related
Frequently asked questions
- What is the strongest alternative to Ozempic in Canada?
- In trials, tirzepatide (Mounjaro, Zepbound) produced more weight loss than semaglutide.
- What are Health Canada-authorized alternatives to Ozempic?
- Authorized options include other semaglutide brands (Wegovy, Rybelsus, 2026 generics), tirzepatide (Mounjaro, Zepbound) and liraglutide (Saxenda, Victoza). All are prescription-only.
- Is compounded semaglutide an alternative in Canada?
- Compounded or 'research' GLP-1 products are not authorized drugs. Health Canada warns they can seriously harm and that 'research use only' labels give no exemption.
- Is retatrutide available in Canada as an Ozempic alternative?
- No. Retatrutide is still investigational and not authorized by Health Canada.
- Will this page tell me which alternative to take or what it costs?
- No. We never publish dosing, prices or sourcing. A licensed Canadian prescriber and pharmacist answer those questions.
Sources
General information only — not medical, legal or regulatory advice. Peptide Confessions does not sell, source or recommend any product or vendor, and nothing here is dosing guidance. Speak with a licensed Canadian healthcare professional or pharmacist about any medication. Editorial process →